Effects of Biased Analogues of the Kappa Opioid Receptor Agonist, U50,488, in Preclinical Models of Pain and Side Effects. [PDF]
van de Wetering R +8 more
europepmc +1 more source
Devaluation of response-produced safety signals reveals circuits for goal-directed versus habitual avoidance in dorsal striatum. [PDF]
Sears RM +8 more
europepmc +1 more source
Sex-dependent modulation of behavioral allocation via ventral tegmental area-nucleus accumbens shell circuitry. [PDF]
McLaurin KA +4 more
europepmc +1 more source
Therapeutic and legal aspects of psilocybin in cancer-related depression. [PDF]
Małgorzata W +3 more
europepmc +1 more source
Novel Synthetic Opioids (NSOs) and Their Evolving Crisis: Utilising NPSfinder® as a Real-Time Predictive Tool. [PDF]
Deligianni E +7 more
europepmc +1 more source
Development of Bioisosteres of Iboga Alkaloids: A Step-Economical Synthesis to Enhance the Antinociceptive and Anxiolytic Activity with Neuroprotective Effects. [PDF]
Gupta A +9 more
europepmc +1 more source
Deconstructing the trip treatment: are hallucinogenic effects critical to the therapeutic benefits of psychedelics? [PDF]
Garcia-Romeu A.
europepmc +1 more source
Recent Insights on Supraspinal Astrocytes in Chronic Pain. [PDF]
Di Spiezio A +3 more
europepmc +1 more source
The renaissance of research on psychedelics in child and adolescent psychopharmacology. [PDF]
Crocq MA, Auby P.
europepmc +1 more source
Pharmacological characterization of the novel selective kappa opioid receptor agonists 10-Iodo-Akuammicine and 10-Bromo-akuammicine in mice. [PDF]
Bland K +10 more
europepmc +1 more source

